The DetectaChem Inc. smartphone-based COVID-19 (Coronavirus) testing solution is designed to work alongside with the company's MobileDetect App for Apple and Android platforms.
As one of the industry-leaders in automated colorimetric detection technologies, DetectaChem has developed a mass-market test to help in the fight against the global COVID-19 pandemic. The new COVID-19 low-cost consumable test kits will be compatible with the globally available MobileDetect App currently in app stores. The test kits will utilize DetectaChem’s MobileDetect pouch technology, which allows a customer to use their own smartphone device to analyze a sample collected with the test kit.
When the test kits are used in conjunction with the free MobileDetect App, a positive or negative COVID-19 result will be determined. With the COVID-19 Test being smartphone-based, it will enable the user to auto-generate reports with time, date, pictures, patient information, medical notations, GPS location and more.
Users will be able to test for COVID-19 quickly and easily with accurate results in 10-30 minutes. The product will follow approved Food and Drug Administration (FDA) methodologies and practices providing utmost user confidence. Users will also be able to streamline communication with medical care providers for immediate instructions on how to proceed. This reporting function will also allow for proactive medical care information regarding incoming COVID-19 patient infections enabling proper allocation of life-saving equipment, such as ventilators in advance.
The MobileDetect COVID-19 test kit is in the final stages of approvals and is planned to launch in April 2020. The currently available free MobileDetect App for Apple and Android smartphone and tablet platforms will be updated with the additional COVID-19 testing capability upon launch. Due to the novel design incorporating simplistic operation along with credible field-testing capability, the COVID-19 test kits can be used by federal, state, local response and medical agencies and after FDA consumer approval, are also planned to be available to the general public.
DetectaChem is proud to be able to provide a low-cost COVID-19 testing solution that can deliver critical and actionable results to millions of concerned families, medical professionals, first responders and others around the world.
Visit www.DetectaChem.com/COVID19 for more information and to receive product release updates and availability information.
